心血管疾病中的外体和外体非编码RNA的生物学
Lu Gan1, Xiaofei Guo2, Shichao Dong3
1Department of Pharmacy, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Frontiers in pharmacology
|June 10, 2025
概括
外体,微小的带有非编码RNA的囊泡,显示出治疗心血管疾病 (CVD) 的希望. 本综述探讨了它们在心血管疾病治疗中的机制和潜力,并提供了对未来治疗方法的见解.
科学领域:
- 生物医学研究的研究.
- 分子生物学分子生物学
- 心脏病学 心脏病学
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因.
- 目前的心血管疾病治疗因预后不佳和心脏重塑而面临限制.
- 对心血管疾病的新型治疗机制需要进一步研究.
研究的目的:
- 审查外体的生理机制.
- 总结关于使用非编码RNA对心血管疾病进行外介导调节的研究.
- 讨论外体在心血管疾病治疗中的治疗潜力和挑战.
主要方法:
- 对外体生理学的文献评论.
- 对心血管研究中的外体非编码RNA研究的分析.
- 对基于外体的心血管疾病治疗方法的当前发现的综合.
主要成果:
- 外体在细胞间通信中起着至关重要的作用.
- 外体非编码RNA是调节心血管疾病发病的关键媒介.
- 在了解心血管疾病中的外体功能方面取得了重大进展.
结论:
- 外体代表了对心血管疾病的有希望的治疗途径.
- 向外体非编码RNA为心血管疾病干预提供了一个新的策略.
- 需要进一步的研究来克服局限性,并实现基于外体细胞的治疗的临床潜力.
更多相关视频
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
63
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
63
Coronary Artery Disease I: Introduction
3
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3


